Novel technologies to diagnose and manage cardiovascular disease

References

• Lancellotti P, Nchimi A. New approaches to cardiovascular diseases. Acta Cardiol. 2023;78(9):977–979. doi:10.1080/00015385.2023.2267925.
   PubMed Web of Science ®Google Scholar
• Harskamp RE, De Clercq L. Performance of ChatGPT as an AI-assisted decision support tool in medicine: a proof-of-concept study for interpreting symptoms and management of common cardiac conditions (AMSTELHEART-2). Acta Cardiol. 2024;79(3):358–366. doi:10.10.1080/00015385.2024.2303528.
   Google Scholar
• Kleebayoon A, Wiwanitkit V. Long-term administration of proton pump inhibitors, risk of adverse cardiovascular outcomes? and ChatGPT. Acta Cardiol. 2023;79(3):402. doi:10.1080/00015385.2023.2238537.
   Google Scholar
• Daungsupawong H, Wiwanitkit V. Performance of ChatGPT as an AI-assisted decision support tool in medicine. Acta Cardiol. 2024;79(3):413. doi:10.1080/00015385.2024.2322185.
   Google Scholar
• Teperikidis E, Boulmpou A, Papadopoulos C. Prompting ChatGPT to perform an umbrella review. Acta Cardiol. 2023;79(3):403–404. doi:10.1080/00015385.2023.2240120.
   Google Scholar
• Lancellotti P, Ribeiro Coelho S, Nguyen Trung ML, et al. Special issue on heart failure. Acta Cardiol. 2023;78(2):165–167. doi:10.1080/00015385.2023.2182985.
   PubMed Web of Science ®Google Scholar
• Lancellotti P. A journey in structural heart failure. Acta Cardiol. 2023;78(10):1065–1067. doi:10.1080/00015385.2023.2281096.
   PubMed Web of Science ®Google Scholar
• Donal E, Brunet A, Galli E. Can we predict the non-response to cardiac resynchronization therapy? Acta Cardiol. 2014;69(4):366–368. doi:10.1080/ac.69.4.3036651.
   PubMed Web of Science ®Google Scholar
• Yuecel G, Stoesslein K, Gaasch L, et al. Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease. Acta Cardiol. 2023;79(3):327–337. doi:10.1080/00015385.2023.2277624.
   Google Scholar
• Zandi Z, Eslami M, Kamali F, et al. Comparison of de novo implantation vs. upgrade cardiac resynchronisation therapy: a multicentre experience. Acta Cardiol. 2023;79(3):338–343. doi:10.1080/00015385.2023.2285539.
   Google Scholar
• Pittie G, Lukas P, Massart M, et al. Evaluation of analytical and clinical performance of the AFIAS Tn-I plus assay – a new point-of-care. Acta Cardiol. 2023;79(3):351–357. doi:10.1080/00015385.2023.2286423.
   Google Scholar
• Lancellotti P, Fattouch K, Modine T. Is transcatheter aortic valve implantation for aortic stenosis cost-effective? Acta Cardiol. 2023;79(1):95–97. doi:10.1080/00015385.2023.2281110.
   PubMed Web of Science ®Google Scholar
• Lempereur M, Nguyen-Trung ML, Petitjean H, et al. Leading trends in pacemaker implantation after aortic valve replacement in Italy. Acta Cardiol. 2023;79(1):101–102. doi:10.1080/00015385.2023.2287305.
   PubMed Web of Science ®Google Scholar
• Lancellotti P, Petitjean H, Postolache A, et al. Focus on valvular heart disease. Acta Cardiol. 2022;77(10):861–863. doi:10.1080/00015385.2022.2159193.
   PubMed Web of Science ®Google Scholar
• Damas F, Nguyen Trung M-L, Postolache A, et al. Cardiac damage and conduction disorders after transcatheter aortic valve implantation. J Clin Med. 2024;13(2):409. doi:10.3390/jcm13020409.
   PubMed Web of Science ®Google Scholar
• Ziacchi M, Spadotto A, Palmisano P, et al. Conduction system disease management in patients candidate and/or treated for the aortic valve disease: an Italian survey promoted by Italian Association of Arrhythmology and Cardiac Pacing (AIAC). Acta Cardiol. 2024;79(3):367–373. doi:10.1080/00015385.2024.2310930.
   Google Scholar
• Lancini D, Smith C, Elkhateeb O, et al. Leadless Micra pacemaker implantation in patient with previous senning procedure for dextro-transposition of the great arteries. Acta Cardiol. 2023;78(3):357–361. doi:10.1080/00015385.2023.2176043.
   PubMed Web of Science ®Google Scholar
• Xu F, Meng L, Lin H, et al. Systematic review of leadless pacemaker. Acta Cardiol. 2023;79(3):284–294. doi:10.1080/00015385.2023.2276537.
   Google Scholar
• Bilehjani E, Fakhari S, Farzin H, et al. Diagnosis and treatment of cardiovascular manifestations of COVID-19: a narrative review. Acta Cardiol. 2023;79(3):267–273. doi:10.1080/00015385.2023.2246200.
   Google Scholar
• Romiti GF, Bonini N, Boriani G. The detrimental interplay between atrial fibrillation and COVID-19: new evidence and unsolved questions. Acta Cardiol. 2024;79(3):410–412. doi:10.1080/00015385.2024.2313938.
   Google Scholar
• Karadavut S, Cetin M, Sahin O. The effect of COVID-19 on the thromboembolic outcomes in atrial fibrillation patients in the long run. Acta Cardiol. 2023;79(3):344–350. doi:10.1080/00015385.2023.2286421.
   Google Scholar
• Omar T, Karakayalı M, Perincek G. Assessment of COVID-19 deaths from cardiological perspective. Acta Cardiol. 2022;77(3):231–238. doi:10.1080/00015385.2021.1903704.
   PubMed Web of Science ®Google Scholar
• Zhang YP, Gao QY, Gao JW, et al. The association between tinnitus and risk of cardiovascular events and all-cause mortality: insight from the UK Biobank. Acta Cardiol. 2024;79(3):374–382. doi:10.1080/00015385.2024.2324222.
   Google Scholar
• Lancellotti P. Focus on cardiometabolic risk factors. Acta Cardiol. 2023;78(5):515–518. doi:10.1080/00015385.2023.2231702.
   PubMed Web of Science ®Google Scholar
• Lancellotti P. Special issue on ischaemic heart disease. Acta Cardiol. 2023;78(8):859–862. doi:10.1080/00015385.2023.2256566.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang FR, Wen FF, et al. The association between sodium/glucose cotransporter-2 inhibitors and adverse clinical events in patients with chronic kidney disease: a systematic review and meta-analysis of randomised controlled trials. Acta Cardiol. 2023;79(3):274–283. doi:10.1080/00015385.2023.2250949.
   Google Scholar
• Snel M, Descamps OS. Long-term safety and effectiveness of alirocumab and evolocumab in familial hypercholesterolemia (FH) in Belgium. Acta Cardiol. 2023;79(3):311–318. doi:10.1080/00015385.2023.2256182.
   Google Scholar
• Karabulut D, Karabulut U, Kalyoncuoğlu M, et al. Predictive value of triglyceride/glucose index for cardiac outcomes in non-diabetic renal transplant recipients. Acta Cardiol. 2023;79(3):319–326. doi:10.1080/00015385.2023.2257983.
   Google Scholar
• Khosravi A, Eghbali M, Najafian J, et al. Prediction of blood pressure based on anthropometric measurements in adolescents. Acta Cardiol. 2023;79(3):304–310. doi:10.1080/00015385.2023.2256180.
   Google Scholar
• Abdel-Hady EA. Chromium picolinate supplementation improves cardiac performance in hypoxic rats. Acta Cardiol. 2022;79(3):387–397. doi:10.1080/00015385.2022.2041782.
   Google Scholar
• Stremmel C, Vdovin N, Kellnar A, et al. Impact of moderate altitude exposure on cardiovascular risk. Acta Cardiol. 2021;79(3):383–386. doi:10.1080/00015385.2021.1976449.
   Google Scholar
• Liu H, Ma XF, Dong N, et al. LncRNA PVT1 inhibits endothelial cells apoptosis in coronary heart disease through regulating MAPK1 expression via miR-532-3p. Acta Cardiol. 2023;79(3):295–303. doi:10.1080/00015385.2023.2209448.
   Google Scholar
• Leelaviwat N, Kewcharoen J, Trongtorsak A, et al. Association between periodontal disease and heart failure: a systematic review and meta-analysis. Acta Cardiol. 2023;79(3):405–409. doi:10.1080/00015385.2023.2259192.
   Google Scholar
• Salaun E, Beaudoin J, Sénéchal M. Conduction disorders in cardiac sarcoidosis. Acta Cardiol. 2024;79(3):400–401. doi:10.1080/00015385.2024.2304462.
   Google Scholar
• Zardi EM, Marra A, Pignatelli M, et al. Unstable angina as a result of coronary steal syndrome due to escape flow from a double large coronary-pulmonary artery fistula. Acta Cardiol. 2023;79(3):398–399. doi:10.1080/00015385.2023.2272552.
   Google Scholar